Results 1 to 10 of about 273,177 (229)

High Expression of MDR-1 Gene and P-Glycoprotein in Initial and Re-Biopsy Specimens of Relapsed B-Cell Lymphoma

Histopathology, 2001
K Ohshima
exaly  

Effects of Pluronic and Doxorubicin on Drug Uptake, Cellular Metabolism, Apoptosis and Tumor Inhibition in Animal Models of MDR Cancers

Journal of Controlled Release, 2010
Alexander Kabanov, Rodney Lee Mosley, Howard E. Gendelman   +2 more
exaly  

Dacomitinib Antagonizes Multidrug Resistance (MDR) in Cancer Cells by Inhibiting the Efflux Activity of ABCB1 and ABCG2 Transporters

Cancer Letters, 2018
Dong-Hua Yang, Leli Zeng, Zhe-Sheng Chen
exaly  

Restoration of Chemosensitivity by Multifunctional Micelles Mediated by P-Gp siRNA to Reverse MDR

Biomaterials, 2014
Qiwen Wang, Paul K. Chu, Jie Shen
exaly  

Efficacy and Safety of Linezolid in Multidrug Resistant Tuberculosis (MDR-TB)—A Report of Ten Cases

Journal of Infection, 2006
exaly  

Transcriptional Regulation of MDR-1 by HOXC6 in Multidrug-Resistant Cells

Oncogene, 2013
exaly  

Lansoprazole (LPZ) Reverses Multidrug Resistance (MDR) in Cancer Through Impeding ATP-Binding Cassette (ABC) Transporter-Mediated Chemotherapeutic Drug Efflux and Lysosomal Sequestration

Drug Resistance Updates
exaly  

‘ZS-MDR-TB’ Versus ‘ZR-MDR-TB’: Improving Treatment of MDR-TB by Identifying Pyrazinamide Susceptibility

Emerging Microbes and Infections, 2012
Indispensable for shortening treatment of drug-susceptible tuberculosis (TB), pyrazinamide (PZA, Z) is also essential in the treatment of multidrug-resistant (MDR)-TB. While resistance to PZA in MDR-TB is associated with poor treatment outcome, bacillary
Wen-Hong Zhang, Kwok Chiu Chang, Dorothy Fallows   +2 more
exaly   +6 more sources

Global Trends in the Incidence Rates of MDR and XDR Tuberculosis: Findings From the Global Burden of Disease Study 2019

Frontiers in Pharmacology, 2023
Purpose: The study aimed to quantify the global trends of the incidence rates of multidrug-resistant (MDR) tuberculosis (MDR-TB) and extensively drug-resistant (XDR) tuberculosis (XDR-TB).Methods: Cases, age-standardized rates (ASRs), and incidence rates
Rong Qiang, Qingting Bu
exaly   +3 more sources

MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis. [PDF]

PLoS ONE, 2017
BACKGROUND:In 2013, approximately 480,000 people developed active multidrug-resistant tuberculosis (MDR-TB), while only 97,000 started MDR-TB treatment.
Emily A Kendall, Andrew S Azman, Frank G Cobelens, David W Dowdy   +3 more
doaj   +2 more sources